Ismael Valladolid-Acebes, Per-Olof Berggren, Lisa Juntti-Berggren. Apolipoprotein CIII as a therapeutic target in obesity-associated metabolic dysfunction. // Advances in Biological Regulation. – DOI: 10.1016/j.jbior.2026.101183. – URL: https://www.sciencedirect.com/science/article/pii/S2212492626000400?dgcid=rss_sd_all
Ismael Valladolid-Acebes, Per-Olof Berggren, & Lisa Juntti-Berggren Apolipoprotein CIII as a therapeutic target in obesity-associated metabolic dysfunction. Advances in Biological Regulation. https://doi.org/10.1016/j.jbior.2026.101183
Ismael Valladolid-Acebes, et al. “Apolipoprotein CIII as a therapeutic target in obesity-associated metabolic dysfunction.” Advances in Biological Regulation. doi:10.1016/j.jbior.2026.101183.
@article{ValladolidAcebes,
title = {Apolipoprotein CIII as a therapeutic target in obesity-associated metabolic dysfunction},
author = {Valladolid-Acebes, Ismael and Berggren, Per-Olof and Juntti-Berggren, Lisa},
journal = {Advances in Biological Regulation},
doi = {10.1016/j.jbior.2026.101183},
url = {https://www.sciencedirect.com/science/article/pii/S2212492626000400?dgcid=rss_sd_all}
}